Verified email-pattern data for Eu Malaria Fund is currently limited. You can still use the company insights and contact sections below.
The EU Malaria Fund is a public-private partnership between the European Union, International Organizations, corporations, and organized civic society, providing a novel funding instrument to address EU Malaria Fund: Transforming Global Health Through Strategic Investment
The EU Malaria Fund is a public-private partnership with the European Union, international organizations, corporations, and civic society to tackle critical market failures in infectious disease innovation.
Investment Phase Complete - Portfolio Deployed
Our strategic investment phase has successfully concluded, deploying capital across high-impact malaria product development projects. We've invested in next-generation vaccine development platforms and breakthrough therapeutic compounds specifically engineered to overcome drug resistance—addressing one of malaria's most pressing challenges.
Three-Market Strategy Driving Impact
Our portfolio targets premium markets (travel/military sectors), volume opportunities through GAVI partnerships, and platform technologies with cross-indication potential extending to neurodegenerative diseases. This diversified approach maximizes social impact and enables commercial viability.
Portfolio Highlights:
Next-generation vaccine platforms with proven milestone achievements
Resistance-breaking therapeutic compounds with promising efficacy profiles
Secondary applications in neurodegeneration and severe asthma
Market Impact at Scale
With 240 million annual malaria cases and climate change expanding endemic zones, our investments address a $9.6 trillion travel industry increasingly exposed to malaria risk. Every dollar invested generates $36 in economic growth within endemic regions through reduced healthcare costs and increased productivity.
Proven Investment Success
All our malaria projects have successfully passed key milestones with positive outcomes. Portfolio companies have secured follow-on grant funding and continue advancing their developments. These projects
Company Details
- Founded
- -
- Address
- Bundesallee 210, Berlin,berlin 10719,germany
- Industry
- Financial Services
- Website
- controlmalaria.eu
- Keywords
- Venture Loans, Malaria, Infectious Diseases, HealthcareInvestment, PublicPrivatePartnership, MalariaInnovation, #GlobalHealth.
- HQ
- Berlin, Berlin
Eu Malaria Fund Questions
EU Malaria Fund's website is controlmalaria.eu
EU Malaria Fund's LinkedIn profile is https://de.linkedin.com/company/eu-malaria-fund
EU Malaria Fund's industry is
Financial Services
EU Malaria Fund's top competitors are
Roaring Ventures,
Px-Lab,
Policentransfer,
Kenup Africa Foundation,
Asia Pacific Malaria Elimination Network (Apmen),
Impact Global Health,
Fidecum - Die Fondsmanufaktur®,
Monalisa Doctoral Network,
Suhling Tooling Gmbh,
Phoenix Innovations Gmbh.
EU Malaria Fund's categories are Financial Services
EU Malaria Fund's founding year is 2020
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.